CAS No. |
143-67-9 |
中文名称 |
(3aR,3a1R,4R,5S,5aR,10bR)-4-乙酰氧基-3a-乙基-9-((5S,9S)-5-乙基-5-羟基-9-(甲氧基甲酰基)-1,4,5,6,7,8,9,10-八氢-2H-3,7-甲桥[1]氮杂环十一烷并[5,4-b]吲哚-9-基)-5-羟基-8-甲氧基-6-甲基-3a,3a1,4,5,5a,6,11,12-八氢-1H-吲哚啉并[8,1-cd]咔唑-5-甲酸甲酯 硫酸盐 |
英文名称 |
methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-9-((3R,5S,7R,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate sulfate |
别名 |
V1193 | Vinblastine, hydrate | CHEBI:9984 | Q27108547 | AKOS024456494 | HMS3676C14 | Belvan, VLB | Vinblastine 5 | Vinblastine sulfate | GLYCIDYL .BETA.-NAPHTHYL ETHER | FT-0603354 | KDQAABAKXDWYSZ-JKDPCDLQSA-N | NSC49842 | Velban (TN) | Vinblastine Sulfa |
标准英文名 |
methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-9-((3R,5S,7R,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate sulfate |
MDL No. |
MFCD00082457 |
分子式 |
C46H60N4O13S |
分子量 |
909.07
|
精确分子量 |
908.39
|
SMILES |
CC[C@@]12[C@@]3([H])[C@]4(CCN3CC=C2)[C@](N(C5=CC(OC)=C([C@@]6(C7=C(CC[N@@]8C[C@](C[C@](O)(C8)CC)([H])C6)C9=CC=CC=C9N7)C(OC)=O)C=C54)C)([H])[C@](O)([C@@H]1OC(C)=O)C(OC)=O.O=S(O)(O)=O |
标准SMILES |
CN1[C@@H]2[C@]3(CCN4CC=C[C@](CC)([C@@H]34)[C@@H](OC(C)=O)[C@]2(O)C(=O)OC)C2=CC(=C(C=C12)OC)[C@]1(C[C@@H]2C[C@](O)(C[N@@](C2)CCC2=C1NC1=CC=CC=C21)CC)C(=O)OC.OS(O)(=O)=O |
用途 |
Vinblastine sulfate is a nationally listed essential medicine primarily used for the treatment of Hodgkin's disease and malignant lymphoma. It is also indicated for choriocarcinoma, breast cancer, bronchogenic carcinoma, soft tissue sarcoma, testicular tumors, ovarian cancer, gastrointestinal cancers, metastatic malignant melanoma, and neuroblastoma. It is one of the most widely used natural plant-derived anticancer agents globally. As a cell cycle-specific antineoplastic agent, it binds to tubulin and inhibits microtubule formation, leading to disruption of mitotic spindle assembly and arrest of tumor cells in the M phase of the cell cycle. It is also effective in the treatment of lymphosarcoma and acute leukemia. |
InChIKey |
KDQAABAKXDWYSZ-PNYVAJAMSA-N |